Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126902501 | 12690250 | 1 | I | 2016 | 20160823 | 20160826 | 20160826 | EXP | US-AMGEN-USASL2016111103 | AMGEN | 65.00 | YR | E | F | Y | 0.00000 | 20160826 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126902501 | 12690250 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, 2 TIMES/WK | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | BIW | ||||||
| 126902501 | 12690250 | 2 | I | ENBREL | ETANERCEPT | 1 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||||||
| 126902501 | 12690250 | 3 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126902501 | 12690250 | 4 | C | HUMALOG | INSULIN LISPRO | 1 | UNK | 0 | |||||||||||
| 126902501 | 12690250 | 5 | C | LEVEMIR | INSULIN DETEMIR | 1 | UNK | 0 | |||||||||||
| 126902501 | 12690250 | 6 | C | DULOXETINE. | DULOXETINE | 1 | UNK | 0 | |||||||||||
| 126902501 | 12690250 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 126902501 | 12690250 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 126902501 | 12690250 | 9 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126902501 | 12690250 | 1 | Fibromyalgia |
| 126902501 | 12690250 | 2 | Psoriasis |
| 126902501 | 12690250 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126902501 | 12690250 | OT |
| 126902501 | 12690250 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126902501 | 12690250 | Concussion | |
| 126902501 | 12690250 | Diabetes mellitus | |
| 126902501 | 12690250 | Drug interaction | |
| 126902501 | 12690250 | Fall | |
| 126902501 | 12690250 | Head injury | |
| 126902501 | 12690250 | Headache | |
| 126902501 | 12690250 | Hypertension | |
| 126902501 | 12690250 | Injection site pain | |
| 126902501 | 12690250 | Loss of consciousness | |
| 126902501 | 12690250 | Neuropathy peripheral | |
| 126902501 | 12690250 | Peripheral artery occlusion | |
| 126902501 | 12690250 | Tinnitus | |
| 126902501 | 12690250 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126902501 | 12690250 | 1 | 2015 | 0 |